• Oculus Innovative Sciences Inc., of Petaluma, Calif., said results of its open-label pilot study testing Microcyn Technology-based Atrapro Antipruritic Hydrogel in combination with Neosalus Cream in atopic dermatitis demonstrated a statistically significant 50 percent reduction in the body surface area of the atopic dermatitis from baseline to week four.